Confirmed six-month disability progression rates over 4 years were similar in patients given the oral statin or a placebo in ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS POST ECTRIMS 2024 Paris, 23 September 2024, 5.45pm CET AB Science SA (Euronext - ...

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and ...

B.Riley Financial analyst William Wood has reiterated their bullish stance on IMUX stock, giving a Buy rating on September 16. William Wood ...

Patients with Parkinson’s disease (PD) suffer from a variety of movement disorders caused by a breakdown of brain neurons.

Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced ...

Beverages like green tea, ginseng tea, coffee, kefir, and some juices may help improve memory, focus, and overall cognitive ...

The new report follows the release earlier this month of data from US states and territories that showed that in 2023, the ...

Longevity is becoming increasingly popular to elongate health-span. We turn to estrogen to understand its impact on women's ...

Maureen Sharphouse made countless visits to countless doctors before she found out she suffered from Ehlers Danlos syndrome.

More and more research suggests that gut microbiome metabolites could hold the key to treating nearly every disease.